From: Prediction of the therapeutic efficacy of epirubicin combined with ifosfamide in patients with lung metastases from soft tissue sarcoma based on contrast-enhanced CT radiomics features
Age
Sex (Male/Female)
PR + SD (n = 57)
PD (n = 29)
Training (n = 60)
46.27 ± 12.73
26/34
40
20
Testing (n = 26)
44.15 ± 16.16
15/11
17
9
t/F value
− 0.65
1.49
0.23
p value
0.517
0.91